Melanoma Research

Melanoma Research

Research into melanoma at Penn State Cancer Institute is conducted by the melanoma and skin cancer team. See current clinical trials and members of that team here.

Clinical Trials

A Children's Oncology Group Protocol for Collecting and Banking Pediatric Research Specimens including Rare Pediatric Tumors.
Protocol for the Enrollment on the Official COG Registry, the Childhood Cancer Research Network (CCRN)
Umbrella Long-term Follow-up Protocol
Efficacy of a Behavioral Intervention to Reduce Skin Cancer Risk Among Patients
Development and Validation of a Gene Expression Assay to Predict the Risk of Metastatic Disease in Malignant Cutaneous Melanoma
A Phase 2 Study of REGN2810, a Fully Human Monoclonal Antibody to Programmed Death-1, in Patients with Advanced Basal Cell Carcinoma who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy or were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy
Development and Validation of a Gene Expression Assay to Predict the Risk of Recurrence Disease in Cutaneous Squamous Cell Carcinoma
The Collection of Blood, Tissue and Phenotypic Data in Patients Diagnosed with Skin Cancers and Subsequent Metastases for Inclusion in a Repository and Use in Outcome Studies
Atypical Spotzoid Melanocytic Tumors: An Institutional Review of Outcomes for an Effective Treatment
Application for Discarded Tissue From Surgery For Research Use
Infrared Lymphangiography as a Method of Sentinel Node Identification (SPY)
Pathology Characteristics of Cutaneous Melanoma in Females and Association with UV Exposure
Definition of Somatic Variants Corresponding to Immune Targets in Patients with Metastatic Melanoma
A Retrospective Evaluation to Understand how â-adrenergic Antagonism Impacts the Progression of Melanoma and the Efficacy of Standard Treatments Intended to Eliminate the Cancer
A Phase 1b, Open-label, Multicenter, Dose-escalation Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma
A Phase I/II, Multicenter, Open-Label, Dose Escalation Study of the Safety and Pharmacokinetics of Cobimetinib in Pediatric and Young Adult Patients with Previously Treated Solid Tumors
The Project: Every Child Protocol: A Registry, Eligibility Screening, Biology and Outcome Study

Disease Team Members

First Name Last Name Title Role
Bryan Anderson, MD Bryan Anderson MD View Profile
Ayodele Ayoola, MD Ayodele Ayoola MD View Profile
Elizabeth Billingsley, MD Elizabeth Billingsley MD View Profile
Amanda Cooper, MD Amanda Cooper MD View Profile
Joseph Drabick, MD, FACP Joseph Drabick MD, FACP View Profile
Diane Hershock, MD, PhD Diane Hershock MD, PhD View Profile
Heath Mackley, MD, FACRO Heath Mackley MD, FACRO View Profile
James Marks, MD James Marks MD View Profile
Rogerio Neves, MD, PhD Rogerio Neves MD, PhD View Profile
Colette R. Pameijer, MD Colette R. Pameijer MD View Profile
Marc Rovito, MD Marc Rovito MD View Profile
Christie Travelute, MD Christie Travelute MD View Profile
Henry Wagner Jr., MD Henry Wagner Jr. MD View Profile
Research into melanoma at Penn State Cancer Institute is conducted by the melanoma and skin cancer team. See current clinical trials and members of that team here.
A Children's Oncology Group Protocol for Collecting and Banking Pediatric Research Specimens including Rare Pediatric Tumors.
Protocol for the Enrollment on the Official COG Registry, the Childhood Cancer Research Network (CCRN)
Umbrella Long-term Follow-up Protocol
Efficacy of a Behavioral Intervention to Reduce Skin Cancer Risk Among Patients
Development and Validation of a Gene Expression Assay to Predict the Risk of Metastatic Disease in Malignant Cutaneous Melanoma
A Phase 2 Study of REGN2810, a Fully Human Monoclonal Antibody to Programmed Death-1, in Patients with Advanced Basal Cell Carcinoma who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy or were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy
Development and Validation of a Gene Expression Assay to Predict the Risk of Recurrence Disease in Cutaneous Squamous Cell Carcinoma
The Collection of Blood, Tissue and Phenotypic Data in Patients Diagnosed with Skin Cancers and Subsequent Metastases for Inclusion in a Repository and Use in Outcome Studies
Atypical Spotzoid Melanocytic Tumors: An Institutional Review of Outcomes for an Effective Treatment
Application for Discarded Tissue From Surgery For Research Use
Infrared Lymphangiography as a Method of Sentinel Node Identification (SPY)
Pathology Characteristics of Cutaneous Melanoma in Females and Association with UV Exposure
Definition of Somatic Variants Corresponding to Immune Targets in Patients with Metastatic Melanoma
A Retrospective Evaluation to Understand how â-adrenergic Antagonism Impacts the Progression of Melanoma and the Efficacy of Standard Treatments Intended to Eliminate the Cancer
A Phase 1b, Open-label, Multicenter, Dose-escalation Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma
A Phase I/II, Multicenter, Open-Label, Dose Escalation Study of the Safety and Pharmacokinetics of Cobimetinib in Pediatric and Young Adult Patients with Previously Treated Solid Tumors
The Project: Every Child Protocol: A Registry, Eligibility Screening, Biology and Outcome Study
First Name Last Name Title Role
Bryan Anderson, MD Bryan Anderson MD View Profile
Ayodele Ayoola, MD Ayodele Ayoola MD View Profile
Elizabeth Billingsley, MD Elizabeth Billingsley MD View Profile
Amanda Cooper, MD Amanda Cooper MD View Profile
Joseph Drabick, MD, FACP Joseph Drabick MD, FACP View Profile
Diane Hershock, MD, PhD Diane Hershock MD, PhD View Profile
Heath Mackley, MD, FACRO Heath Mackley MD, FACRO View Profile
James Marks, MD James Marks MD View Profile
Rogerio Neves, MD, PhD Rogerio Neves MD, PhD View Profile
Colette R. Pameijer, MD Colette R. Pameijer MD View Profile
Marc Rovito, MD Marc Rovito MD View Profile
Christie Travelute, MD Christie Travelute MD View Profile
Henry Wagner Jr., MD Henry Wagner Jr. MD View Profile

Clinical Trials Search


Children (age < 18 years)
Adults (age >= 18 years)